New Zealand markets closed

Fresenius Medical Care AG (FMCQF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
42.74+0.81 (+1.94%)
At close: 12:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.54B
Enterprise value 23.91B
Trailing P/E 23.90
Forward P/E 12.29
PEG ratio (5-yr expected) 0.46
Price/sales (ttm)0.59
Price/book (mrq)0.85
Enterprise value/revenue 1.14
Enterprise value/EBITDA 15.28

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 3-7.23%
S&P500 52-week change 326.14%
52-week high 349.86
52-week low 334.33
50-day moving average 339.89
200-day moving average 340.81

Share statistics

Avg vol (3-month) 3225
Avg vol (10-day) 3550
Shares outstanding 5293.41M
Implied shares outstanding 6294.33M
Float 8198.93M
% held by insiders 132.17%
% held by institutions 138.99%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.29
Forward annual dividend yield 43.02%
Trailing annual dividend rate 31.19
Trailing annual dividend yield 32.84%
5-year average dividend yield 41.30
Payout ratio 467.80%
Dividend date 3N/A
Ex-dividend date 417 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 2.48%
Operating margin (ttm)7.65%

Management effectiveness

Return on assets (ttm)2.83%
Return on equity (ttm)4.72%

Income statement

Revenue (ttm)19.47B
Revenue per share (ttm)66.37
Quarterly revenue growth (yoy)0.40%
Gross profit (ttm)N/A
EBITDA 2.51B
Net income avi to common (ttm)483.59M
Diluted EPS (ttm)1.79
Quarterly earnings growth (yoy)-17.80%

Balance sheet

Total cash (mrq)1.15B
Total cash per share (mrq)3.91
Total debt (mrq)12.06B
Total debt/equity (mrq)79.68%
Current ratio (mrq)1.50
Book value per share (mrq)47.40

Cash flow statement

Operating cash flow (ttm)2.61B
Levered free cash flow (ttm)1.17B